AusPAR: Catumaxomab

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

1 April 2014
AusPAR Details
AusPAR
Active Ingredient
Catumaxomab
Product Name
Removab
Sponsor
Biotech Regulatory Solutions
Submission Number
PM-2010-03132-3-4
Submission Type
New chemical entity
Decision
Rejected
AusPAR Date
11 March 2014
Publication Date

1 April 2014